Carcinogenicity of N-alkyl-N-(acetoxymethyl)nitrosamines after subcutaneous injections in F-344 rats. 1982

A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima

As model compounds for metabolically activated N,N-dialkylnitrosamines, five N-alkyl-N-(acetoxymethyl)nitrosamines were synthesized and their carcinogenicity was tested in F-344 rats of both sexes. Compounds used in this study are N-methyl-(MAMN), N-ethyl-(EAMN), N-propyl-(PAMN), N-butyl-(BAMN), and N-isobutyl-N-(acetoxymethyl)nitrosamines (i-BAMN). All chemicals were dissolved in olive oil and rats received 10 weekly subcutaneous injections of these chemicals (10 X 5 mg MAMN or equimolar amounts of other chemicals) at the interscapular region. Subcutaneous tumors were detected in many rats of all groups treated with the chemicals, although no tumor was detected in the control group. Lung and/or thyroid tumors were also observed in many rats in the experimental groups. The incidence of subcutaneous tumors was highest in EAMN, followed in order by MAMN, PAMN, BAMN, and i-BAMN. On the contrary, the incidence of lung and thyroid tumors was highest in MAMN and decreased as the length of the alkyl chain of the chemicals increased. Histologically, almost all subcutaneous tumors were malignant fibrous histiocytomas. The results indicate that the chemicals possess systemic as well as local carcinogenicity in F-344 rats. The potent carcinogenic effects at the injection site of the alpha-acetoxy nitrosamines, coupled with their direct mutagenic activity reported previously, support the notion that these derivatives are useful as models for the ultimate form in the metabolic activation of N,N-dialkylnitrosamines.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D005260 Female Females
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
August 1986, Carcinogenesis,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
June 1983, Toxicology,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
May 1978, Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
January 1982, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
April 1991, Carcinogenesis,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
August 1982, Gan,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
January 1982, Cancer letters,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
January 1983, Carcinogenesis,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
January 1982, Fundamental and applied toxicology : official journal of the Society of Toxicology,
A Maekawa, and T Ogiu, and H Onodera, and K Furuta, and C Matsuoka, and M Mochizuki, and T Anjo, and M Okada, and S Odashima
August 1980, Journal of the National Cancer Institute,
Copied contents to your clipboard!